There are two trials that I think are probably the most excited about. One of them is called the PEAK trial, and it was a ...
GISTs are a rare type of cancer that develops in the digestive tract’s connective tissue, specifically from cells that help regulate muscle contractions. GISTs are primarily driven by genetic ...
It is vital to acknowledge early symptoms, seek specialized care, as well as an expert opinion when it comes to gastrointestinal stromal tumor treatment. It is vital to pay attention to your body and ...
NEW YORK, March 18, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, today announced breakthrough preclinical findings demonstrating the ...
Gastrointestinal stromal tumors (GISTs) represent a rare tumor entity that occurs in the muscular layer of the digestive tract. These tumors commonly metastasize to the liver and peritoneum, and ...
Fred Hutchinson Cancer Center-led investigators found that higher patient-reported fatigue before cancer treatment aligned ...
New Data Demonstrates Significant Reduction in Tumor Growth and KIT Expression in Preclinical GIST Models Induction of Tumor Cell Death – HT-KIT triggered significant tumor cell death as early as 24 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results